Voglibose Tablets I.P. 0.3 mg CDBOSE 0.3 10x10 Tablets

ITC-HSN: 300490

Price on Request

Min Order Qty 1

  • Product not available

Voglibose Tablets I.P. 0.3 Mg Cdbose 0.3 is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Voglibose IP 0.3 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this alpha-glucosidase inhibitor tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable postprandial blood glucose control medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this anti-diabetic tablet formulation a dependable addition to a pharmaceutical importer's product portfolio.


Features:

  • Composition: Voglibose IP 0.3 mg
  • Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
  • Available in tablets form for ease of storage, handling, and dispensing
  • Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
  • Export-ready 10x10 Tablets packing designed for bulk international shipment
  • Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

  • Brand / Seller: CD&M Remedies
  • Product Category: Anti-Diabetic Medication (Alpha-Glucosidase Inhibitor)
  • Dosage Form: Tablets
  • Pack Size: 10x10 Tablets
  • Pharmacopeial Standard: Indian Pharmacopoeia (IP)
  • Product Code: 1002

Business Operations: Merchant

Contact us for


By clicking on ‘Send Trade Enquiry’, you agree to our terms & condition and user policies

Product Overview

Voglibose is an alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus, primarily to help control post-meal (postprandial) blood glucose spikes. It is commonly prescribed alongside other antidiabetic therapies.


Composition & Specifications

Each unit of this alpha-glucosidase inhibitor tablet contains Voglibose IP 0.3 mg, formulated in tablets form and manufactured in compliance with Indian Pharmacopoeia (IP) standards. This ensures uniform potency and quality across every production batch, a key requirement for pharmaceutical importers and distributors evaluating postprandial blood glucose control medication for their regional markets.


Application & Usage

This formulation is used in the management of type 2 diabetes as part of a physician-directed treatment regimen, particularly for controlling post-meal glucose elevation. Intended for pharmacy, hospital, and institutional distribution channels.


Packaging & Export Readiness

Supplied in 10x10 blister strip configuration, providing a compact and tamper-evident export pack format. The 10x10 Tablets configuration is widely used in international pharmaceutical trade, supporting efficient inventory management for wholesalers and institutional buyers sourcing anti-diabetic tablet formulation in bulk quantities.


Why Source From CD&M Remedies

CD&M Remedies is an established manufacturer of IP-compliant pharmaceutical formulations, supplying alpha-glucosidase inhibitor tablet to B2B buyers and importers worldwide. Buyers benefit from consistent formulation quality, reliable supply capability, and export-oriented packing suited to cross-border pharmaceutical trade.


Q: What is the composition of Voglibose Tablets I.P. 0.3 Mg Cdbose 0.3?
A: It contains Voglibose IP 0.3 mg, manufactured to Indian Pharmacopoeia (IP) standards in tablets form.

Q: What pack sizes are available for Voglibose Tablets I.P. 0.3 Mg Cdbose 0.3?
A: This product is supplied in 10x10 Tablets export packing, suitable for wholesale and institutional bulk orders.

Q: Who manufactures Voglibose Tablets I.P. 0.3 Mg Cdbose 0.3?
A: Voglibose Tablets I.P. 0.3 Mg Cdbose 0.3 is manufactured and supplied by CD&M Remedies, under product code 1002.

Q: Which product category does Voglibose Tablets I.P. 0.3 Mg Cdbose 0.3 belong to?
A: It falls under the Anti-Diabetic Medication (Alpha-Glucosidase Inhibitor) category, intended for B2B pharmaceutical buyers and importers.

Established in: 2016
Bussiness Type: Private Limited
Bussiness Type: Merchant
MSME: No
Export Turnover (3 years): Less than US$10,000
Countries would like to export to: Algeria, Angola, Congo The Democratic Republic Of The, Egypt, Ghana, Guatemala, Nigeria, Senegal, South Africa
No of employees: 1-10

Related Products